How do you pay?

How to pay the least

Ask for the cash price

Neupro

No generic is sold yet.

  1. Ask your pharmacy for Neupro’s cash price, and one or two other pharmacies too.
  2. Neupro’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify UCB Patient Assistance Program. A patient’s total gross household income cannot exceed 500% of the Federal Poverty Limit (FPL). Or call (877) 785-8906.

See if you qualify 

Compare every option

Question
Brand nameNeupro
Authorized genericrotigotine
Regular genericrotigotine
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Neupro?
The original
–
–

Brand nameThe maker’s card

NEUPRO Patient Savings Card

Savings card from UCB

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $10 a month

The card takes up to $1,500 a year off your co-pay.

Sign up on neupro.com 

Or call 1-855-841-0263. See the offer on neupro.com

In the maker’s words

“Eligible commercial patients may pay as little as $10 per 30-day supply of NEUPRO…”

From the maker’s offer on neupro.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Neupro itself, from the same company, sold without the brand name, and usually for less. For now Neupro is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

NEUPRO is a dopamine agonist indicated for the treatment of:

  • Parkinson's disease
  • Moderate-to-severe primary Restless Legs Syndrome

Source: the FDA label for Neupro (UCB, Inc.), September 10, 2026. Full label on DailyMed 

Good to know